Single-cell mosaicism analysis reveals cell-type-specific somatic mutational burden in Alzheimer’s Dementia

Despite significant advances in identifying genetic drivers of neurodegenerative disorders, the majority of affected individuals lack molecular genetic diagnosis, with somatic mutations proposed as one potential contributor to increased risk. Here, we report the first cell-type-specific map of somatic mosaicism in Alzheimer’s Dementia (AlzD), using 4,014 cells from prefrontal cortex samples of 19 AlzD and 17 non-AlzD individuals. We integrate full-transcript single-nucleus RNA-seq (SMART-Seq) with matched individual-level whole-genome sequencing to jointly infer mutational events and the cell-type in which they occurred. AlzD individuals show increased mutational burden, localized in excitatory neurons, oligodendrocytes, astrocytes and disease-associated “senescent” cells. High-mutational-burden cells showed mutational enrichment and similar single-cell expression profiles in AlzD cases versus non-AlzD individuals, indicating cellular-level genotype-to-phenotype correlation. Somatic mutations are specifically enriched for known AlzD genes, and implicate biologically meaningful cell-type specific processes, including: neuronal energy regulation, endocytic trafficking (NEFM), lipid metabolism (CNP, CRYAB), proteostasis (USP34), cytoskeleton, and microtubule dynamics (MACF1).

[1]  Derek H. Oakley,et al.  Somatic genomic changes in single Alzheimer’s disease neurons , 2022, Nature.

[2]  R. Yao,et al.  Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles , 2020, Autophagy.

[3]  Ernesto Picardi,et al.  Investigating RNA editing in deep transcriptome datasets with REDItools and REDIportal , 2020, Nature Protocols.

[4]  James B. Brewer,et al.  Brain cell type–specific enhancer–promoter interactome maps and disease-risk association , 2019, Science.

[5]  Nick C Fox,et al.  Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing , 2019, Nature Genetics.

[6]  J. Vilo,et al.  g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update) , 2019, Nucleic Acids Res..

[7]  Manolis Kellis,et al.  Single-cell transcriptomic analysis of Alzheimer’s disease , 2019, Nature.

[8]  Nick C Fox,et al.  Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing , 2019, Nature Genetics.

[9]  Gregory M. Cooper,et al.  CADD: predicting the deleteriousness of variants throughout the human genome , 2018, Nucleic Acids Res..

[10]  Mark Gerstein,et al.  GENCODE reference annotation for the human and mouse genomes , 2018, Nucleic Acids Res..

[11]  V. Gorgoulis,et al.  Ageing, Cellular Senescence and Neurodegenerative Disease , 2018, International journal of molecular sciences.

[12]  M. Fornage,et al.  Whole exome sequencing study identifies novel rare and common Alzheimer’s-Associated variants involved in immune response and transcriptional regulation , 2018, Molecular Psychiatry.

[13]  M. Strong,et al.  Dysregulation of human NEFM and NEFH mRNA stability by ALS-linked miRNAs , 2018, Molecular Brain.

[14]  Samuel F. Bakhoum,et al.  Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations , 2018, Nature.

[15]  David A Bennett,et al.  Religious Orders Study and Rush Memory and Aging Project. , 2018, Journal of Alzheimer's disease : JAD.

[16]  D. Goldstein,et al.  Whole‐exome sequencing in 20,197 persons for rare variants in Alzheimer's disease , 2018, Annals of clinical and translational neurology.

[17]  A. Brickman,et al.  White matter changes in Alzheimer’s disease: a focus on myelin and oligodendrocytes , 2018, Acta neuropathologica communications.

[18]  K. B. Manheimer,et al.  Robust identification of mosaic variants in congenital heart disease , 2018, Human Genetics.

[19]  Hans-Ulrich Klein,et al.  A multi-omic atlas of the human frontal cortex for aging and Alzheimer’s disease research , 2018, Scientific Data.

[20]  Yue Feng,et al.  Novel schizophrenia risk factor pathways regulate FEZ1 to advance oligodendroglia development , 2017, Translational Psychiatry.

[21]  Peter J. Park,et al.  Aging and neurodegeneration are associated with increased mutations in single human neurons , 2017, Science.

[22]  M. Viitanen,et al.  PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease , 2017, Stem cell reports.

[23]  S. Quake,et al.  Single-Cell Analysis of Human Pancreas Reveals Transcriptional Signatures of Aging and Somatic Mutation Patterns , 2017, Cell.

[24]  M. Hurles,et al.  Somatic mutations reveal asymmetric cellular dynamics in the early human embryo , 2017, Nature.

[25]  R. J. Kelleher,et al.  Presenilin-1 mutations and Alzheimer’s disease , 2017, Proceedings of the National Academy of Sciences.

[26]  T. Hortobágyi,et al.  Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss , 2016, Brain : a journal of neurology.

[27]  Beth K. Martin,et al.  Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism. , 2016, JAMA neurology.

[28]  B. Taylor,et al.  deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution , 2016, Genome Biology.

[29]  S. Sunyaev,et al.  Genes with monoallelic expression contribute disproportionately to genetic diversity in humans , 2016, Nature Genetics.

[30]  Youssra K Al-Hilaly,et al.  Nuclear Tau and Its Potential Role in Alzheimer’s Disease , 2016, Biomolecules.

[31]  C. Walsh,et al.  Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms , 2015, Neuron.

[32]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[33]  Peter J. Park,et al.  Somatic mutation in single human neurons tracks developmental and transcriptional history , 2015, Science.

[34]  Lourens J P Nonkes,et al.  Genetic Mapping in Mice Reveals the Involvement of Pcdh9 in Long-Term Social and Object Recognition and Sensorimotor Development , 2015, Biological Psychiatry.

[35]  M. Murray,et al.  Mitochondrial ATP synthase activity is impaired by suppressed O-GlcNAcylation in Alzheimer's disease. , 2015, Human molecular genetics.

[36]  SangYun Kim,et al.  Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders , 2015, Clinical interventions in aging.

[37]  Andreas R. Pfenning,et al.  Activity-Induced DNA Breaks Govern the Expression of Neuronal Early-Response Genes , 2015, Cell.

[38]  Shannon L. Risacher,et al.  Hippocampal transcriptome-guided genetic analysis of correlated episodic memory phenotypes in Alzheimer's disease , 2015, Front. Genet..

[39]  Manolis Kellis,et al.  Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease , 2015, Nature.

[40]  S. Gabriel,et al.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.

[41]  Boris Yamrom,et al.  The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.

[42]  Feng Zhang,et al.  In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9 , 2014, Nature Biotechnology.

[43]  Paul Theodor Pyl,et al.  HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.

[44]  Heng Li,et al.  Toward better understanding of artifacts in variant calling from high-coverage samples , 2014, Bioinform..

[45]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[46]  Åsa K. Björklund,et al.  Full-length RNA-seq from single cells using Smart-seq2 , 2014, Nature Protocols.

[47]  Henning Hermjakob,et al.  The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..

[48]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[49]  Jin Billy Li,et al.  RADAR: a rigorously annotated database of A-to-I RNA editing , 2013, Nucleic Acids Res..

[50]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[51]  C. Walsh,et al.  Somatic Mutation, Genomic Variation, and Neurological Disease , 2013, Science.

[52]  Thomas W. Mühleisen,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease , 2013, Nature Genetics.

[53]  Christine Van Broeckhoven,et al.  Genetic insights in Alzheimer's disease , 2013, The Lancet Neurology.

[54]  J. Mill,et al.  CNP and DPYSL2 mRNA expression and promoter methylation levels in brain of Alzheimer's disease patients. , 2012, Journal of Alzheimer's disease : JAD.

[55]  F. Real,et al.  Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome , 2012, Nature Genetics.

[56]  Evan T. Geller,et al.  Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.

[57]  Pablo Cingolani,et al.  © 2012 Landes Bioscience. Do not distribute. , 2022 .

[58]  H. Kampinga,et al.  The HSPB8‐BAG3 chaperone complex is upregulated in astrocytes in the human brain affected by protein aggregation diseases , 2012, Neuropathology and applied neurobiology.

[59]  B. Goellner,et al.  The synaptic cytoskeleton in development and disease , 2012, Developmental neurobiology.

[60]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[61]  Kossay Zaoui,et al.  ErbB2 receptor controls microtubule capture by recruiting ACF7 to the plasma membrane of migrating cells , 2010, Proceedings of the National Academy of Sciences.

[62]  Pavel V. Baranov,et al.  DARNED: a DAtabase of RNa EDiting in humans , 2010, Bioinform..

[63]  Sudha Seshadri,et al.  Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.

[64]  P. Bosco,et al.  Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease , 2009, Nature Genetics.

[65]  H. Katoh,et al.  Regulation of dendrite growth by the Cdc42 activator Zizimin1/Dock9 in hippocampal neurons , 2009, Journal of neuroscience research.

[66]  David A. Bennett,et al.  Mixed brain pathologies account for most dementia cases in community-dwelling older persons , 2007, Neurology.

[67]  M. Gatei,et al.  Senataxin, defective in ataxia oculomotor apraxia type 2, is involved in the defense against oxidative DNA damage , 2007, The Journal of cell biology.

[68]  David A. Bennett,et al.  Decision Rules Guiding the Clinical Diagnosis of Alzheimer’s Disease in Two Community-Based Cohort Studies Compared to Standard Practice in a Clinic-Based Cohort Study , 2006, Neuroepidemiology.

[69]  Ryan E. Mills,et al.  An initial map of insertion and deletion (INDEL) variation in the human genome. , 2006, Genome research.

[70]  Haruo Ichikawa,et al.  Interaction between p230 and MACF1 is associated with transport of a glycosyl phosphatidyl inositol-anchored protein from the Golgi to the cell periphery. , 2004, Experimental cell research.

[71]  J. Schneider,et al.  Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. , 2004, Archives of neurology.

[72]  D. A. Bennett,et al.  Natural history of mild cognitive impairment in older persons , 2002, Neurology.

[73]  Jeffrey L. Cummings,et al.  Cognitive and behavioral heterogeneity in Alzheimer’s disease: seeking the neurobiological basis , 2000, Neurobiology of Aging.

[74]  C. Finch,et al.  Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. , 1995, Brain research. Molecular brain research.

[75]  J. Hardy,et al.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene , 1991, Nature.

[76]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[77]  S. Matsuyama,et al.  Hypothesis: microtubules, a key to Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[78]  H. Wiśniewski,et al.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[79]  M. Kirschner,et al.  A protein factor essential for microtubule assembly. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[80]  B. Yan,et al.  Clonal hematopoiesis and blood-cancer risk. , 2015, The New England journal of medicine.

[81]  D. Hafler,et al.  Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination. , 2007, Nature.

[82]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[83]  J. Trojanowski,et al.  Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology. , 2004, The American journal of pathology.

[84]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[85]  M A Pericak-Vance,et al.  Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. , 1993, Neurology.